MétaCan
Menu
← Back to cohort
Record W7132966913

Early signatures of cancer evolution from cell-free DNA methylation profiling in pre-diagnosis biologics

2025· dissertation· W7132966913 on OpenAlexaboutno aff
Nicholas Cheng

Bibliographic record

VenueTSpace · 2025
Typedissertation
Language
FieldBiochemistry, Genetics and Molecular Biology
TopicCancer Genomics and Diagnostics
Canadian institutionsnot available
Fundersnot available
KeywordsBreast cancerDNA methylationProstate cancerBiomarker discoveryBiomarkerCancerPopulationDisease
DOInot available

Abstract

fetched live from OpenAlex

Cell-free DNA (cfDNA) has been highlighted as a promising biomarker for early cancer detection owing to the capability of non-invasively detecting DNA methylation signatures and mutations concordant with the originating tumour in blood. While many studies have been able to demonstrate the capability of utilizing plasma cfDNA biomarkers to distinguish cancer patients from healthy individuals, most of these findings have profiled from individuals with late-stage or established cancers that were detected through conventional screening or from clinical follow-up following onset of symptoms. Evaluating the clinical utility of emerging biomarkers for early disease detection requires application of new technologies to biologics collected from asymptomatic individuals prior to diagnosis. By leveraging biologics collected in the Ontario Health Study longitudinal population cohort, genome-wide cfDNA methylome profiling was performed on blood plasma of incident breast and prostate cancer cases collected up to nine years prior to diagnosis, in addition to matched cancer-free controls. Across both cancer types, observed cfDNA differentially methylated regions (DMRs) in discovery cohort samples were significantly enriched for regulatory elements particularly in promoter and enhancer regions. Notably, target genes of these regions were highly associated with gene sets involved in tumour growth and survival, inflammation, and various metabolic processes. Building on these insights, predictive models trained and tuned using cfDNA DMRs identified from discovery set samples were evaluated in held-out test data. Across both breast and prostate cancers, cfDNA DMRs were highly predictive of early cancer up to eight years prior to diagnosis, even capable of identifying individuals with early breast cancers despite a negative mammogram screen prior to blood collection. Furthermore, cfDNA methylome signatures were also capable of stratifying individuals at high and low-risk of developing cancers, highlighting an alternative application of cfDNA biomarkers. Collectively, this work provides further insights into the signatures of early cancer evolution through cfDNA methylome analysis. By interrogating pre-diagnosis biologics, I highlight potential biological processes driving early cancer development and demonstrate potential applications from early detection and risk stratification, to identifying potential molecular targets for early cancer prevention.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.002
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Bench or experimental · Consensus signal: none
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.019
Threshold uncertainty score0.037

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0010.002
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0010.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.010
GPT teacher head0.303
Teacher spread0.293 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designBench or experimental
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2025
Admission routes1
Has abstractyes

Explore more

Same venueTSpace→Same topicCancer Genomics and Diagnostics→French-language works237,207→